Author:
Chakrabarti Gaurab,Silvers Molly A.,Ilcheva Mariya,Liu Yuliang,Moore Zachary R.,Luo Xiuquan,Gao Jinming,Anderson Glenda,Liu Lili,Sarode Venetia,Gerber David E.,Burma Sandeep,DeBerardinis Ralph J.,Gerson Stanton L.,Boothman David A.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. ACS . Cancer Facts and Figures 2014. Atlanta: American Cancer Society (2014).
2. Maginn, E. N., de Sousa, C. H., Wasan, H. S. & Stronach, E. A. Opportunities for translation: targeting DNA repair pathways in pancreatic cancer. Biochimica et biophysica acta 1846, 45–54 (2014).
3. Awadallah, N. S. et al. NQO1 expression in pancreatic cancer and its potential use as a biomarker. Applied immunohistochemistry & molecular morphology: AIMM/official publication of the Society for Applied Immunohistochemistry 16, 24–31 (2008).
4. Glen, V. L., Hutson, P. R., Kehrli, N. J., Boothman, D. A. & Wilding, G. Quantitation of beta-lapachone and 3-hydroxy-beta-lapachone in human plasma samples by reversed-phase high-performance liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications 692, 181–186 (1997).
5. Pink, J. J. et al. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. The Journal of biological chemistry 275, 5416–5424 (2000).
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献